Illumina's Board Elects Two Independent Directors; Stephen MacMillan Named Non-Executive Chair Of Board
Portfolio Pulse from Benzinga Newsdesk
Illumina's board has elected two new independent directors, Stephen P. MacMillan, CEO of Hologic, and Scott B. Ullem, CFO of Edwards Lifesciences. MacMillan will also serve as the non-executive Chair of Illumina's board.
June 02, 2023 | 11:35 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Illumina elects two new independent directors, strengthening its board with the addition of Hologic CEO Stephen MacMillan and Edwards Lifesciences CFO Scott Ullem.
The addition of two experienced executives from the medical device and diagnostics industry to Illumina's board is likely to have a positive impact on the company's strategic direction and decision-making. This could lead to improved performance and increased investor confidence in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100